AKT1 and pancreatic neoplasm: Another study conducted by Wei and collaborators (2019) [56] reported the proteolysis of this kinase and inhibition of p-Akt (Ser473) in pancreatic cancer (PANC-1 and MIA PaCa-2) cell lines exposed to epigallocatechin-3-gallate and gemcitabine treatment.